Nucleic acid therapies: AAV-based epigenetic perturbation - from translational disease models to anti-arrhythmic strategies
- Funding ID
81X4500124
- Project number
1802
- Institution
- Universität Heidelberg
- Project leader
- Ralf Gilsbach
- Site
- Heidelberg/Mannheim
- Project type
- Innovation Cluster
- Funding
- € 775.185,00
- Begin
- 01.11.2023
- End
- 31.10.2026
- Partner projects